Aug 04, 2020 4:01pm EDT Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program
Jul 28, 2020 7:30am EDT Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update
Jul 27, 2020 7:30am EDT Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology
Jul 14, 2020 7:30am EDT Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia
Jul 09, 2020 8:19am EDT Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
Jun 17, 2020 7:30am EDT Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
Jun 11, 2020 7:30am EDT Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
Jun 03, 2020 7:30am EDT Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
May 05, 2020 4:01pm EDT Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
